NCG
KRMD icon

Newport Capital Group’s KORU Medical Systems KRMD Stock Holding History

Newport Capital Group’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-69,079
Closed -$247K – 62
2023
Q2 		$247K Hold
69,079
– – 0.12% 60
2023
Q1 		$247K Buy
+69,079
New +$272K 0.28% 17

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Newport Capital Group's KRMD Position: Q3 2023 in Review

Newport Capital Group sold out of KORU Medical Systems (KRMD) in Q3 2023, closing a stake of 69,079 shares — an estimated $247K sold.

Newport Capital Group first reported a position in KRMD in Q1 2023 and held it in 2 quarters. The position peaked at $247K in Q2 2023. 55 funds tracked by Wall St. Rank hold KRMD as of Q3 2023.

  • Newport Capital Group reported no remaining KORU Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Newport Capital Group sold 69,079 KORU Medical Systems shares in Q3 2023, an estimated $247K.
  • Newport Capital Group first reported a position in KORU Medical Systems in Q1 2023 and held it in 2 quarters.
  • Newport Capital Group's KORU Medical Systems position peaked at $247K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2023.

Based on Newport Capital Group's 13F filing for Q3 2023, filed 14 Nov 2023.